Our Employees
and Advisers

Dr. Rajvir Dahiya is a Professor Emeritus of Urology at the University of California San Francisco, School of Medicine (UCSF). He has 38 years of expertise in medical oncology research focusing on genetics and epigenetic of various cancers with 400 publications.

Rajvir Dahiya, M.S., Ph.D., M.D., D.Sc.

Founder, CEO and President

Dr. Deng is a retired Medical Oncology researcher from the University of California San Francisco School of Medicine (UCSF). He has 45 years of expertise in medical oncology, cancer genetics and epigenetic research with 200 publications.

Guoren Deng, M.D.

Chief Scientific Officer

Dr. M. Allen Northrup is an elected Member, National Academy of Engineering , Bioengineering Section and American Institute of Medical and Biological Engineers. He is a co-founder of Cepheid Inc. He has more than 30 years of expertise in the field of PCR technology and testing.

M. Allen Northrup, Ph.D.

Scientific Adviser

Dr. Dharam P. Chauhan is a retired Professor of Gastroenterology and Hepatology Oncology from University of California San Diego (UCSD) School of Medicine. He has 34 years of expertise in medical oncology, genetics and epigenetics research.

Dharam Paul Chauhan M.S., Ph.D.

Vice-President

Dr. Konety is currently The Henry P. Russe, MD, Dean of Rush University Medical College. He is also the Senior Vice President for Clinical Affairs, Rush University System for Health. He is a Professor of Surgery, Urology with more than 25 years of experience in clinical trials and oncology research with 300 publications.

Badrinath R. Konety, M.D., M.BA.

Scientific / Clinical Adviser

Dr. Sanjay Gupta is a Professor and holds Carter Kissell Endowed Chair in Urologic Oncology in the Department of Urology at Case Western Reserve University and the position of Research Director at the Urology Institute, University Hospitals Cleveland Medical Center. He has 25 years of expertise in the field of medical oncology, genetics and epigenetic research with 180 publications.

Sanjay Gupta, M.S., Ph.D.

Scientific Adviser

Dr. Hari K. Koul is Professor and Associate Director for the Stanley S Scott Cancer Center/Head of the GU Oncology Research Program at LSUHSC. He concurrently serves as Professor and Interim Head of the Department of Biochemistry and Molecular Biology LSUHSC-School of Medicine. He has 25 years of expertise in the field of medical oncology, genetics and epigenetic research with 120 publications.

Hari K Koul, M.Sc., PhD, FACN, FASN

Scientific Adviser

Dr. Menon is the founding director of Vattikuti Distinguished Chair of the Vattikuti Urology Institute (UVI) at the Henry Ford Hospital in Detroit, MI, where he established the first cancer-oriented robotics program in the world. Since 1983, he has been a Professor and Chairman of urology at highly prestigious universities in the USA and published 700 papers.

Mani Menon, M.D.

Scientific / Clinical Adviser

Dr. Tewari is a Chairman, Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai is a world-renowned urologist and prostate cancer specialist. He has more than 25 years of expertise in the field of clinical trials and oncology research with more than 250 publications.

Ashutosh K. Tewari, M.B.B.S.,M.D.

Scientific / Clinical Adviser

Dr. Kakar is a Professor of Anatomic Pathology at the University of California San Francisco School of Medicine (UCSF); Chief and Director, Gastrointestinal-Hepatobiliary Pathology Service. He has more than 25 years of expertise in clinical research with 135 publications in high impact journals.

Sanjay Kakar, M.D.

Scientific / Clinical Adviser

Dr. Okuyama is a President of Osaka Yukioka School of Medical Technology affiliated institute on allied health of Osaka University. He is a Professor Emeritus and formal Chairman of Urology at Osaka University. He has more than 50 years of expertise in clinical trials and research with 400 publications.

Akihiko Okuyama, M.D., Ph.D.

Scientific / Clinical Adviser

Dr. Nonomura is a Professor and Chairman, Department of Urology, Osaka University Graduate School of Medicine , Osaka, Japan. He is a Vice president, Osaka University Hospital , Osaka, Japan. He has more than 30 years of expertise in clinical trials and research with 200 publications.

Norio Nonomura, M.D., Ph D.

Scientific / Clinical Adviser

Dr. Nakagawa is an Advisor of Urology at Imamura General Hospital, Kagoshima, Japan. He was a Professor and Chairman (1999-2021) of Urology Department, Kagoshima University Faculty of Medicine. He has more than 35 years of expertise in the field of clinical trials and research with 180 publications.

Masayuki Nakagawa, M.D., Ph.D.

Scientific / Clinical Adviser

Dr. Nakajima is Professor and Chairman, Department of Urology since 2011 at Toho University School of Medicine, Tokyo, Japan. He has more than 22 years of expertise in the field of clinical trials and research with 150 publications.

Koichi Nakajima M.D., Ph.D.

Scientific / Clinical Adviser

Dr. Enokida is a Chairman and Professor, Department Urology, Graduate of School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. He received his MD, PhD from the Kagoshima University Faculty of Medicine. He has more than 20 years expertise in clinical trials and medical oncology research with 150 publications.

Hideki Enokida, M.D., Ph.D.

Scientific / Clinical Adviser

Dr. Ganguly is a Professor of Eminence, Translational Health Science & Technology Institute, India. President, Apollo Hospitals Educational and Research Foundation.He was a Director General of Indian Council of Medical Research (ICMR) and Director of PGI Chandigarh. He has more than 45 years of expertise in clinical research with 775 publications.

Nirmal Kumar Ganguly, M.B.B.S., M.D.

Scientific / Clinical Adviser

Dr. Kumar is a Chairman, Department of Urology,uro-oncology, Robotics & Renal Transplant, Max group of Hospital Delhi. He was a Professor and Chairman of Urology at the Sanjay Gandhi PGI Lucknow. He has more than 35 years of expertise in clinical trials and medical oncology research with 200 publications.

Anant Kumar, M.B.B.S., M.S., M.CH., DNB

Scientific / Clinical Adviser

Dr, Ragavan is a senior consultant Urological Surgeon and Uro-Oncologist (Robotics and Laparoscopy) at Apollo Hospitals, Chennai, India. He has more than 25 years of expertise in clinical research.

Narasimhan Ragavan, M.B.B.S., M.S. (General Surgery), FRCS (Urology)

Scientific / Clinical Adviser

Dr. Raghunath is a Director, Dept of Uro-oncology and Robotic surgery, HCG Cancer Hospital. Cofounder and Director, Trustwell hospital, Bangalore, India. He has more than 20 years of expertise in clinical trials and oncology research.

S.Krishnappa Raghunath, M.B.B.S., M.S. (General Surgery), DNB (Residency in Urology)

Scientific / Clinical Adviser

Dr. Ginil Kumar Pooleri is a Clinical Professor at the Amrita Institute of Medical Science, Amrita Viswavidyapeeth University, Kochi, Kerala, India. He has more than 20 years of expertise in clinical research and trials.

Ginil Kumar Pooleri, M.B.B.S., M.S. (Surgery), M.Ch. (Urology), DNB (Urology)

Scientific / Clinical Adviser

Dr. Shiv Srivastava is a cancer scientist with expertise in epigenetic and genetics of various cancers. He was a Professor and Director of the Center for Prostate Disease Research (CPDR)/Prostate Cancer Center of Excellence at the Uniformed Services University of the Health Sciences for 25 years (1993-2018) with 200 publications.

Shiv Srivastava, M.S., Ph.D.

Scientific Adviser

Dr. Rawal is a Medical Director and Chief of Urology Oncology at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India. He has more than 25 years of expertise in clinical research and trials with 150 publications.

Sudhir K. Rawal, M.B.B.S., M.S (General Surgery), M.CH, D.N.B. (Urology)

Scientific / Clinical Adviser

Dr. Mehta is a Head (Emeritus), Cancer Biology Division IIT Research Institute. Professor (Emeritus) Illinois Institute of Technology, Chicago, IL. He has more than 40 years of expertise in the field of basic and clinical research with more than 300 publications.

Rajendra Mehta, Ph.D.

Scientific Adviser

Allen C. Gao, MD, PhD., is the Ralph deVere White Endowed Professor, Director of Urologic Research, Department of Urology and UC Davis Comprehensive Cancer Center at University of California at Davis, Sacramento, CA. He has more than 25 years of expertise in the field of genetics and epigenetic of various cancers with 130 publications..

Allen C. Gao, M.D., Ph.D.

Scientific / Clinical Adviser

Dr. Mehta is a Director of Molecular diagnostic services and transfusion Medicine; Director of Research and Biorepository at the Rajiv Gandhi Cancer Institute and Research Centre at New Delhi. He did his MBBS from Maulana Azad Medical College, Delhi University in 1976. Dr. Mehta did his MD (Pathology) from the Armed Forces Medical College, Pune University in 1982.

Anurag Mehta, M.D. (Pathology)

Scientific Adviser

Dr. Dabas did his MBBS from the Maulana Azad Medical College, Delhi University, 2003; MS – General Surgery – Lady Hardinge Medical College, New Delhi, 2007; DNB – Surgical Oncology – National Board of Examination, India, 2011.

Dr. Surender Kumar Dabas, MBBS, MS General Surgery, DNB-Surgical Oncology

Scientific / Clinical Adviser

Visit Us

3517 Breakwater Ave
Hayward, CA 94545

Contact us

Follow us

© 2025 GeneVerify Inc.